A trial of antigen-specific immune tolerance induction in mucopolysaccharidosis I (MPS I) patients initiating enzyme replacement therapy with Aldurazyme® (laronidase)

To evaluate the antibody response to Aldurazyme in newly treated severe MPS I patients following an antigen-specific immunosuppressive regimen.